Member Info for GloriaMarket

Investors are very tense going into tomorrow. Everyone is asking themselves whether the NICE news is already priced in or not. Personally I think it is. My feeling is that traders EXPECT GDRs test to be mentioned very positiviely in the NICE announcement, anything less than that and the SP will fall. But who knows? I certainly do not!

"Peel Hunt selling prior to much anticipated news......WHY?????"

Mr Slacker, Peel Hunt saved GDR from going under through purchasing the remaining shares which were not bought by PI's. This led Peel Hunt to own 20% of GDR (as registered in the TR1 RNS's) . Why did Peel Hunt buy the remaining shares @1.5p? I believe they did this because they've made an awful lot of money off GDR over the years and concluded that if they let GDR go bust (by not buying the remaining shares in the placement offer) that Peel Hunt themselves would lose a valuable and profitable client. They sold at least 10% of the company to PI's during June and July, as described in the TR1 RNS's , that they were legally obliged to release. Why did they sell ? Because they don't want to own 20% of GDR, they just wanted GDR to continue as an ongoing concern, as they make alot of money with very little risk by acting as a broker and market maker for GDR (and not as an ii). PH have successfully and unsurprisingly sold alot of shares for profit (I suspect they knew good news would increase the interest against which they could off-load). IMO they are not interested in holding long term as it's arisk they are not prepared to take. Having said that, does anyone know if Peel Hunt is still a major shareholder as the RNS's dried up, but I assume they kept on selling.

Thankyou for correcting me!

"The Group's operating expenses are expected to ramp up to circa £0.65m per month during calendar year 2025 as it funds various growth initiatives.'"

Good point Mr BigAl, obviously working with FDA on the breakthrough programme is a growth initiative however I was wrong in my assumption that GDRs cashburn has increased now.

"Therefore, we must take it that Our Monthly cash burn is still c.£400k, for the rest of 2024, at least, unless Our BOD's inform us otherwise ?!!!"

I'm sure breakthrough programme will incur costs but it was assumption I must've made based on another post at some point. I can't quite remember now. I apologize for misleading people, I've obviously been mislead myself!

"Where is the money coming for unit manufacturing??"

Private investors, Mr Slacker. cash burn is now £600k (or is it £650k?) per month. More funding will be required after the new year, january or february. Peel Hunt assisted the round of funding at the end of May by purchasing the remaining shares (what was that £3M worth? ) and selling them june/july/august. Peel hunt maybe happy to assist next year too. Faily that GDR still have the remaining million of the River fort deal to fall back on, if required. Sales will help increase the SP but I believe the sales won't be enough to keep the lights on. I believe the company stated that it hopes to become profitable by august 2025 so more funding is definitely required next year at some point. But not even Mr Cheek is prepared to invest in GDR long term, at least not significantly. Doesn't mean the SP won't rise temporarily on news, especially if Mr Cheek bought shares. In my view the sp has already risen significantly from 1.8p to roughly 4p based on FDA news. I can't help but feel that NICE news is priced in, although there may be a brief intraday rise and fall). But my opinions are only as relevent as anyone elses on this board as none of us can predict the future sp! GLA.

Mr spodulike,

Turn your screen the right way up.

"Yes and don't forget that GDR went from 9p to 173p in 3 months, between March 2020 and May 2020. GDR also had a rapid climb from 41p to 146p in 2021 and GDR went from 12p - 30p in March 2022. Last year GDR soared from 8p to 32p on positive news. It looks like we might be at the start of a new GDR share price surge based on the previous GDR share price action."

And sp rosé from 1.5p to 4+p in june/july 2024.

Are there companies now offering short products on GDR? I recall previously that short financial products were not offered anywhere...

" when lab testing isn’t available the Genedrive point of care test should be used."

hit the nail on the head, Mr JimiHendrix.

Does he work for a lab which will perform the tests?

Is StockSaint a financial guru?

One thing I've learned is that it's pointless to knock rampers and derampers alike and comments on lse does not move the SP.

DYOR!

"The mms are trying to hid this back for whatever reason."

Good comment. mms read the lse board. If no-one has mentioned mms then they get quite annoyed and start messing about with the sp. In that sense, they are just like spoilt children looking for attention, so lets not forget to give them a mention every hour or so.

"I look at the RNS’s issued and generally browse the chats."

Comment of the week. I think this applies to 90% of AIMS traders.

"Everyone is a trader be it short or long term we are all trading, that’s the point of buying shares, to make money, it’s called trading."

Perhaps this is why companies are leaving AIM, it no longer attracts investors, only short term traders that only become investors when they make mistakes.

I recall this chat board loved Mr Starres during the covid days. He was the rampers ramper, even confidently calculating that the SP should be 600p and the covid tests would be approved by FDA within weeks. I recall Mr Starres stating he owned hundreds of thousands of shares, far more than the CEO. Then, after all those years of flagrant, unashamed ramping whilst the SP fell from 300p to 12p, he sold . Perhas he said he sold @30p but shortly after selling his position his ramps became deramps. Mr Starres turned into anithesis of his former self and his deramping was as shameless has his ramping. Yet, unlike the covid periodm, when Mr Starres ramped as the SP fell, his deramping proved to be correct - much to the frustration of many on this board. That is until this month, as the SP rose from the ashes of 1.5p placement to 4p today. Over the years this stock has always had a champion deramper. I recall the first "jihad4UK". He based the stock all the way from 120p down to 20p, as I recall. As investors, it is no good pulling the wool over our eyes. GDR is very risky for investors and even traders. The safest punt to place on GDR has always been a short. I've never done that myself , I want GDR to succeed. But those with short positions on GDR must surely be the most profitable. Lets hope the tide has turned. GLA.

Lse is all about how many "likes" investors receive for their comment rather than facts that help other investors. However, some posters buck the trend regardless and say what they truly feel. Mr stocksaint is like Nigel Farage in that regard.

£3m? That will be the share price. DYOR.

It's obvious to me that Mr Stocksaint is the owner of a company with testing laboratories and see GDR as its direct competitor.

"Stock, you must be very pleased watching this plummet now after all your efforts this weekend to undermine any confidence and sentiment. Well done. Bravo"

Do you think people base trades on what Mr StockSaint writes on LSE? Is Mr Stocksaint a financial markets guru? DYOR!

Mr StockSaint, are you a financial market guru, do you have a twitter account with 10000's followers?

Certainly the future everyone talks about in health care. I feel GDR need to get the pricing right in order to become the preferred choice. Its obviously to me that POC kits need to be standardized so that all sports of tests canbe used with it. Not just gdr tests but tests developered by other biotech companies. Personalized and point of care tests and medicine should be in every home, as common as small bottle of multivitamins. We have it with pregnancy and Covid tests.

"2nd thing is , NHS would like to push the genetic testing through the community pharmacies without involving the lab."

Mr Lionel1, This Sounds v promising. Where did you read that?